𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions

✍ Scribed by Ellen B. Fung; Paul R. Harmatz; Meredith Milet; Vinod Balasa; Samir K. Ballas; James F. Casella; Lee Hilliard; Abdullah Kutlar; Kenneth L. McClain; Nancy F. Olivieri; John B. Porter; Elliott P. Vichinsky; the Multi-Center Iron Overload Research Group

Book ID
109144150
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
110 KB
Volume
48
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Patterns of hepatic iron distribution in
Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease
✍ Nilesh R. Ghugre; Ignacio Gonzalez-Gomez; Ellen Butensky; Leila Noetzli; Roland πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 2 views

## Abstract Patients with sickle cell disease (SCD) appear to be at lower risk of endocrinopathies and cardiac dysfunction than those with thalassemia major (TM). Circulating redox active iron is lower in these patients, possibly due to increased systemic inflammation and circulating cytokines. Hep

Spleen R2 and R2* in iron-overloaded pat
Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major
✍ Casey J. Brewer; Thomas D. Coates; John C. Wood πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 365 KB

## Abstract ## Purpose To evaluate the magnetic properties of the spleen in chronically transfused, iron‐overloaded patients with sickle cell disease (SCD) and thalassemia major (TM) and to compare splenic iron burdens to those in the liver, heart, pancreas, and kidneys. ## Materials and Methods

Morbidity and mortality in chronically t
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload
✍ Ellen B. Fung; Paul Harmatz; Meredith Milet; Samir K. Ballas; Laura De Castro; W πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 2 views

## Abstract A natural history study was conducted in 142 Thalassemic (Thal), 199 transfused Sickle Cell Disease (Tx‐SCD, __n__ = 199), and 64 non‐Tx‐SCD subjects to describe the frequency of iron‐related morbidity and mortality. Subjects recruited from 31 centers in the US, Canada or the UK were si

Red blood cell transfusions and iron ove
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
✍ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie